Skip to main content
. Author manuscript; available in PMC: 2016 Feb 4.
Published in final edited form as: Pharmacotherapy. 2013 Sep 9;33(12):1299–1307. doi: 10.1002/phar.1342

Figure 2.

Figure 2

Persistence by duration of use, longest episode/patient. Captopril and repaglinide, which are both indicated for chronic use, are represented as comparator drugs to test if the dataset and analytic approach could detect chronic prescription drug use, when present. (Data source: Source Healthcare Analytics Source Lx, 2002–2011.)